Skip to main content

Capricor Therapeutics, Inc.

CAPR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001133869

No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Capricor Therapeutics, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of CAPR: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders1154132+21
Shares14.5M94.5K27.4M+13.1M (+91.0%)
Value$104.1M$695.7K$790.7M+$687.2M (+664.6%)

4 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (45)

Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to CAPR in Q4 2025
InstitutionSharesValue% of portfolio
Suvretta Capital Management, LLC1,785,610$51.5M1.28%
Tang Capital Management LLC1,700,000$49.1M2.42%
Ra Capital Management, L.P.1,507,844$43.5M0.45%
Darwin Global Management, Ltd.800,000$23.2M0.47%
Soleus Capital Management, L.P.646,390$18.7M0.79%
SB Capital Management Inc400,001$11.5M4.23%
Balyasny Asset Management LLC352,998$10.2M0.02%
Boxer Capital Management, LLC325,000$9.38M2.05%
RTW Investments, LP250,000$7.21M0.07%
Palo Alto Investors LP226,304$6.53M0.91%
Moody Aldrich Partners LLC208,755$6.02M1.12%
Diadema Partners LP158,075$4.56M2.72%
Adage Capital Partners GP, L.L.C.130,000$3.75M0.01%
Ameriprise Financial Inc125,169$3.61M0.00%
Seven Grand Managers, LLC100,000$2.89M0.22%
Superstring Capital Management LP96,334$2.78M1.49%
Fred Alger Management, LLC80,793$2.33M0.01%
Anson Funds Management LP68,018$1.96M0.27%
Simplex Trading, LLC55,707$1.61M0.05%
Persistent Asset Partners Ltd51,481$1.49M0.71%
Jump Financial, LLC49,500$1.43M0.02%
Creek Drive Management Group LLC36,000$1.04M0.77%
Glenmede Trust Co NA32,090$926.1K0.00%
Jain Global LLC21,700$626.3K0.01%
Acadian Asset Management LLC20,100$579.0K0.00%
FORA Capital, LLC19,969$576.3K0.07%
StemPoint Capital LP17,853$515.2K0.09%
Creative Planning15,232$439.6K0.00%
Entropy Technologies, LP14,170$408.9K0.02%
Susquehanna Portfolio Strategies, LLC13,295$383.7K0.01%
SEI Investments Co12,610$363.9K0.00%
Quantinno Capital Management LP12,389$357.5K0.00%
Stoneridge Investment Partners LLC8,457$244.0K0.17%
Brinker Capital Investments, LLC8,266$238.6K0.00%
ProShare Advisors LLC7,033$203.0K0.00%
GoalVest Advisory LLC2,050$59.2K0.01%
ACT Capital Management, LLC1,500$43.3K0.04%
Aster Capital Management (DIFC) Ltd526$15.2K0.01%
UBS Asset Management Americas Inc252$7.27K0.00%
Parallel Advisors, LLC247$7.13K0.00%
DV Equities, LLC100$2.89K0.00%
SageView Advisory Group, LLC20$5780.00%
Rothschild Investment LLC18$5190.00%
Bare Financial Services, Inc17$4910.00%
Wolff Wiese Magana LLC6$1740.00%

Sold out (24)

Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (4)

Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CAPR in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Wolverine Trading, LLC70,924$525.5K
Sheets Smith Investment Management14,862$107.2K
Point72 Asia (Singapore) Pte. Ltd.8,215$59.2K
Point72 (DIFC) Ltd516$3.72K